Member Info for WeTookPelham

UK company Scancell developing vaccine to fight COVID-19 variants
By Sara Dorn

February 13, 2021 | 7:06pm

https://nypost.com/2021/02/13/uk-company-developing-vaccine-to-fight-covid-19-variants/

I assume a lot of news stories are syndicated i.e. like Reuters for example, who provide stories to many news outlets, or do they just copy and paste other media outlet articles?

Anyway now on Metro newspaper and MSN too.

Merely a suggestion, but for those of you with Twitter accounts, it would be worth liking and retweet those posts that have appeared on Scancells twitter page today, in particular Albert Arthurs, IMO.

https://twitter.com/scancellpharma

North America seems to have a keen interest it seems?

Fair enough Nomlungu, but the likes of BioNtech and Curevac haven't been diluted by "partnering" with bigger pharma have they? In fact their share prices/market caps look healthier than ever I think?

Nomlungu...a strange tone of posting today? In particular the odd post about needed £100's millions/dilution etc?

Especially considering its arguably the press day Scancell have ever had and the potential for short term news is significant IMO. No longer a SCLP investor?

https://www.youtube.com/watch?v=9Auq9mYxFEE

Go back about 28 min (at time of writing).

"...clinical trial within weeks"...did I hear that right!? Around the bit with Cobra Biologics.

P.s. great spot cc24601

...?
The Times article was good, but this more specific piece is more significant IMO.

"13/2/2021
13:27 inanaco: well well well ... that worked i sent a Private message via twitter to Jennifer Rigby after her last report on vaccines i explained Scancells position and the replay came back "" Thanks, this is really helpful!"" first time i have had a reply from the press"

For those of you don't frequent the other forum.

Just read that on ADVFN, the leading headline on the front page!!!! :-O

https://www.telegraph.co.uk/

Scancell also retweeting the University of Nottingham press office's Tweet RE the times article:

https://twitter.com/UoNPressOffice/status/1360226535387586565

"SCANCELL Retweeted
UoN Press Office
@UoNPressOffice
While the focus so far has been on the virus’s spikes, other jab makers keep an eye on the ball. Find out what Professor Lindy Durrant is currently working on in "

https://www.thetimes.co.uk/article/rapid-covid-mutations-mean-the-scientists-can-never-stand-still-c53fdzxfs

These UT's are having a substantial impact on the share price (relative to their size), what could be the motive for this? MM's using them to scare people i.e. mini tree shakes?

A very tight spread towards the end of the day?

Fyi...did a dummy sell (a precarious business btw!),could sell 250k+ but not dummy buy 250k+, anyone else getting the same?

P.s. for balance there was a delayed sell from this morning for 230k, but think the buys outweigh sells? An up tick in volume yesterday and today it seems either way.
But any idea why LSE is stuck showing -5% when everywhere is showing different?

Well one person is very confident then anyway.

Btw we never RNS's for the recent big buys from 3-4 weeks ago, so not director buys it seems.

Hi Hasiba, I'm of the belief that news around Covidity could drop at any time, you don't concur?

W T P ;)

https://www.gurufocus.com/news/1294048/redmile-group-llc-buys-adc-therapeutics-sa-gilead-sciences-inc-oak-street-health-inc-sells-principia-biopharma-inc-momenta-pharmaceuticals-inc-biontech-se

Interesting.... Redmile bought into Gilead last November... So at the very least there is some connection.

Can't see how much they bought though.

As mentioned Scancell now have 728 followers, whilst it may not seem many but relatively speaking a decent percentage increase from not that long ago.
https://twitter.com/scancellpharma

Maybe more of interest (or completely inconsequential ) is who Scancell follow themselves, as far as i can tell they are following only three other bio/pharma type companies, VacciTech (Oxford/Tech connection?), BioNtech (fully understandable) and interestingly(?) Gilead.

Now as far as I can tell they're not in the covid vaccine sector? Remdisivir is theirs though it seems?
https://www.gilead.com/purpose/advancing-global-health/covid-19

They like big acquisitions too:
https://www.bloomberg.com/news/articles/2020-09-13/gilead-said-to-near-immunomedics-bid-worth-more-than-20-billion